Wesfarmers’ new health division delivers $2.78b revenue

But PBS changes, increased competition, inflation and reduced COVID-19 anti-viral demand have a negative future impact Wesfarmers’ health division, built on the back of last year’s acquisition of Australian Pharmaceutical Industries (API) and its Priceline retail pharmacy banner, has reported $2.78 billion in revenue and just $27 million in earnings before interest and taxes (EBIT).

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Phan first to gain PSA accreditation
Next Watch: Flourish in pharmacy - practical pathways to better teamwork Part 2